<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134838">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01346332</url>
  </required_header>
  <id_info>
    <org_study_id>CPR005021</org_study_id>
    <nct_id>NCT01346332</nct_id>
  </id_info>
  <brief_title>Healthy Volunteer Study</brief_title>
  <acronym>IPSHS</acronym>
  <official_title>Performance of the Iontophoresis System With Headset in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acclarent</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acclarent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will recruit healthy volunteers to undergo the iontophoresis procedure using the
      Acclarent Iontophoresis System with Headset.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores on visual analog scale</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Anesthesia of Tympanic Membrane</condition>
  <arm_group>
    <arm_group_label>Anesthetization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Iontophoresis System with Headset</intervention_name>
    <description>Iontophoresis of an anesthesia solution to the tympanic membrane using the Acclarent Iontophoresis System with Headset</description>
    <arm_group_label>Anesthetization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 2 years old

        Exclusion Criteria:

          -  Pregnant or lactating females

          -  Subject with a history of sensitivity or reaction to lidocaine, tetracaine,
             epinephrine, or any hypersensitivity to local anesthetics of the amide type, or any
             component of the drug solution

          -  Significant atrophic or perforated tympanic membrane

          -  Otitis externa

          -  Damaged or denuded skin in the auditory canal

          -  Electrically sensitive subjects and subjects with electrically sensitive support
             systems (pacemakers, defibrillators, etc.)

          -  Cerumen impaction resulting in a significant amount of cleaning required to visualize
             the tympanic membrane

          -  Evidence of Otitis Media at day of procedure, or within the past three (3) months
             prior to procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Roberson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CEI Medical Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CEI Medical Group</name>
      <address>
        <city>East Palo Alto</city>
        <state>California</state>
        <zip>94303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 14, 2014</lastchanged_date>
  <firstreceived_date>April 29, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
